Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-05

Clinical Trial Update: Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating whether Vitamin D supplementation can prevent bone loss in people with multiple sclerosis and osteoporosis. The trial status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (cholecalciferol) supplementation (cholecalciferol)

Snippet

Sponsor: University Hospital of North Norway | Conditions: Multiple Sclerosis, Osteoporosis | Phase 4 | Status: COMPLETED